← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
69 ta ish
Ish: The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko, Abhishek D. Garg, Agnieszka Kaczmarek +3
Sharh maqola20124 iqtibosABIDetection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková +7
Sharh maqola20203 iqtibosABIPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4
Sharh maqola20163 iqtibosABIUsing immunotherapy to boost the abscopal effect
Wilfred Ngwa, Omoruyi Credit Irabor, Jonathan D. Schoenfeld +3
Sharh maqola20183 iqtibosABIL-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors
Kwangsoo Kim, Jae‐Ho Jeong, Daejin Lim +9
Maqola20152 iqtibosABIMitochondrial dysfunction and oxidative stress in heart disease
Jessica N. Peoples, Anita Saraf, Nasab Ghazal +2
Sharh maqola20192 iqtibosABIReactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo +1
Sharh maqola20202 iqtibosABIAnti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
Jihane Boustani, Benoît Lecoester, Jérémy Baude +4
Sharh maqola20212 iqtibosABI